Literature DB >> 19965068

Engineering analysis and development of the spheroid reservoir bioartificial liver.

Malcolm B McIntosh1, Stephen M Corner, Bruce P Amiot, Scott L Nyberg.   

Abstract

A significant demand exists for a liver support device such as a Bioartifical Liver (BAL) to treat patients experiencing acute liver failure. This descriptive paper outlines the design and development of two of the key components of the Mayo Spheroid Reservoir Bioartificial Liver (SRBAL) system. One of the components is the multifunctional Spheroid Reservoir and the other is Multi-shelf Rocker. The Spheroid Reservoir provides an environment to support the viability and functionality of the hepatocyte spheroids at very high cell densities. The Spheroid Reservoir is the biologically active component of this extracorporeal liver support device. Since the Spheroid Reservoir is designed to support 200-400 grams of hepatocyte spheroids, a method to quickly produce large quantities of spheroids is required. The Multi-Shelf Rocker fulfills the production requirement by allowing the culturing of up to six liters of hepatocyte suspension in a conventional laboratory incubator. The SRBAL is designed to provide life sustaining liver-like function to patients in acute liver failure.

Entities:  

Mesh:

Year:  2009        PMID: 19965068      PMCID: PMC2929141          DOI: 10.1109/IEMBS.2009.5334687

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  8 in total

1.  Burden of liver disease in the United States: summary of a workshop.

Authors:  W Ray Kim; Robert S Brown; Norah A Terrault; Hashem El-Serag
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

Review 2.  Assessment of artificial liver support technology.

Authors:  M L Yarmush; J C Dunn; R G Tompkins
Journal:  Cell Transplant       Date:  1992       Impact factor: 4.064

3.  Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver.

Authors:  Scott L Nyberg; Joseph Hardin; Bruce Amiot; Upendra A Argikar; Rory P Remmel; Piero Rinaldo
Journal:  Liver Transpl       Date:  2005-08       Impact factor: 5.799

4.  Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency.

Authors:  M S Margulis; E A Erukhimov; L A Andreiman; L M Viksna
Journal:  Resuscitation       Date:  1989-10       Impact factor: 5.262

Review 5.  Artificial and bioartificial liver support.

Authors:  Travis J McKenzie; Joseph B Lillegard; Scott L Nyberg
Journal:  Semin Liver Dis       Date:  2008-05       Impact factor: 6.115

6.  Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function.

Authors:  Colleen M Brophy; Jennifer L Luebke-Wheeler; Bruce P Amiot; Harris Khan; Rory P Remmel; Piero Rinaldo; Scott L Nyberg
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

7.  Clinical extracorporeal hybrid liver support--phase I study with primary porcine liver cells.

Authors:  I M Sauer; D Kardassis; K Zeillinger; A Pascher; A Gruenwald; G Pless; M Irgang; M Kraemer; G Puhl; J Frank; A R Müller; T Steinmüller; J Denner; P Neuhaus; J C Gerlach
Journal:  Xenotransplantation       Date:  2003-09       Impact factor: 3.907

8.  Formation of porcine hepatocyte spheroids for use in a bioartificial liver.

Authors:  A Lazar; M V Peshwa; F J Wu; C M Chi; F B Cerra; W S Hu
Journal:  Cell Transplant       Date:  1995 May-Jun       Impact factor: 4.139

  8 in total
  5 in total

1.  Cold storage of porcine hepatocyte spheroids for spheroid bioartificial liver.

Authors:  Yi Li; Harvey S Chen; Mohammed Shaheen; Dong Jin Joo; Bruce P Amiot; Piero Rinaldo; Scott L Nyberg
Journal:  Xenotransplantation       Date:  2019-04-10       Impact factor: 3.907

2.  Advancements in in vitro hepatic models: application for drug screening and therapeutics.

Authors:  Apeksha Damania; Era Jain; Ashok Kumar
Journal:  Hepatol Int       Date:  2013-12-05       Impact factor: 6.047

3.  Serum-free medium and mesenchymal stromal cells enhance functionality and stabilize integrity of rat hepatocyte spheroids.

Authors:  Ji Bao; James E Fisher; Joseph B Lillegard; William Wang; Bruce Amiot; Yue Yu; Allan B Dietz; Yaakov Nahmias; Scott L Nyberg
Journal:  Cell Transplant       Date:  2012-09-21       Impact factor: 4.064

4.  Liver Cell Culture Devices.

Authors:  B Andria; A Bracco; G Cirino; R A F M Chamuleau
Journal:  Cell Med       Date:  2010-07-01

Review 5.  Organotypic liver culture models: meeting current challenges in toxicity testing.

Authors:  Edward L LeCluyse; Rafal P Witek; Melvin E Andersen; Mark J Powers
Journal:  Crit Rev Toxicol       Date:  2012-05-15       Impact factor: 5.635

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.